Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Non Operating Income (2017 - 2025)

Organogenesis Holdings (ORGO) has 9 years of Non Operating Income data on record, last reported at $2.2 million in Q4 2025.

  • For Q4 2025, Non Operating Income rose 8185.19% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.3 million, up 11280.0%, while the annual FY2025 figure was $2.3 million, 11280.0% up from the prior year.
  • Non Operating Income reached $2.2 million in Q4 2025 per ORGO's latest filing, up from -$1.6 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $8.3 million in Q4 2021 and bottomed at -$3.4 million in Q3 2021.
  • Average Non Operating Income over 5 years is $115750.0, with a median of -$24000.0 recorded in 2022.
  • Peak YoY movement for Non Operating Income: tumbled 24566.67% in 2022, then soared 8185.19% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $8.3 million in 2021, then crashed by 99.93% to $6000.0 in 2022, then plummeted by 8883.33% to -$527000.0 in 2023, then soared by 94.88% to -$27000.0 in 2024, then skyrocketed by 8185.19% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non Operating Income were $2.2 million in Q4 2025, -$1.6 million in Q3 2025, and $742000.0 in Q2 2025.